Ohio opioid genetic study reaches milestone in enrollment

Ohio Attorney General Dave Yost says the state's opioid genetic study has hit an enrollment milestone.

COLUMBUS — Ohio Attorney General Dave Yost said an enrollment milestone has been reached in the genetic study of opioid use disorder undertaken by his Scientific Committee on Opioid Prevention and Education.

SCOPE began work on the unprecedented study last year, aiming to identify the genetic factors that make some individuals more susceptible than others to developing an opioid addiction.